View in EDS HTML Full Text PDF Full Text

THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.

Saved in:
Bibliographic Details
Title: THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.
Authors: Apolónio, Joana Dias1,2,3,4 (AUTHOR), Dias, João S.5 (AUTHOR), Fernandes, Mónica Teotónio2,3,6 (AUTHOR), Komosa, Martin4,7 (AUTHOR), Lipman, Tatiana4,7 (AUTHOR), Zhang, Cindy H.4,7 (AUTHOR), Leão, Ricardo8 (AUTHOR), Lee, Donghyun4,7 (AUTHOR), Nunes, Nuno Miguel4,7 (AUTHOR), Maia, Ana-Teresa1,3,9 (AUTHOR), Morera, José L.5 (AUTHOR), Vicioso, Luis10 (AUTHOR), Tabori, Uri4,7,11 (AUTHOR), Castelo-Branco, Pedro1,2,3,12 (AUTHOR) pjbranco@ualg.pt
Source: Clinical Epigenetics. 12/18/2022, Vol. 14 Issue 1, p1-22. 22p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:18687075
DOI:10.1186/s13148-022-01396-3